Home » Newsletters » BioWorld Asia

BioWorld Asia

March 8, 2000

View Archived Issues

CAT Proposes #100M Offering, Enters Antibody Deal With HGS

OECD Conference On GM Foods Ends With Call For Further Talks

Flamel Raises $12.8M Privately Through Sale To Venture Funds

Compugen Raises Profile Through Broad HGS Deal

GPC, Atugen Forge Alliance To Provide Genomics Platform

Cannabinoids Prove Helpful In Controlling MS Symptoms

Rhein Biotech Pays $110M To Buy Korean Green Cross

Ofer Bros. Establish $50M Fund Dedicated To Biotech

New Merlin Fund Expected To Help Private Companies

Alizyme Gets Patent, License For Drug To Treat Mucositis

Evotec Enters Alliance With Sugen To Screen Libraries

Genset, Abbott Sign New Deal To Find Bipolar, Diabetes Genes

Stem Cell Sciences Proceeds With Licensing Technology

SignalGene Buys GeneScape To Add Genomics Capability

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...